Source:http://linkedlifedata.com/resource/pubmed/id/18508316
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2008-6-23
|
pubmed:abstractText |
Transforming growth factor-beta (TGF-beta) plays a dual and complex role in human cancer. In this report, we observe a specific set of MicroRNAs (miRNAs) changed in response to TGF-beta in human hepatocellular carcinoma (HCC) cells by miRNA microarray screening. A cluster of miRNA, miR-23a approximately 27a approximately 24, is induced in an early stage by TGF-beta in Huh-7 cells. Knockdown of Smad4, Smad2 or Smad3 expression by RNA interference can attenuate the response of miR-23a approximately 27a approximately 24 to TGF-beta addition, indicating that this induction is dependent on Smad pathway. We also explore that miR-23a approximately 27a approximately 24 can function as an antiapoptotic and proliferation-promoting factor in liver cancer cells. In addition, expression of this miRNA cluster is found to be remarkably upregulated in HCC tissues versus normal liver tissues. These findings suggest a novel, alternative mechanism through which TGF-beta could induce specific miRNA expression to escape from tumor-suppressive response in HCC cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1097-0215
|
pubmed:author |
pubmed-author:DingJieJ,
pubmed-author:GuJianrenJ,
pubmed-author:HeXianghuoX,
pubmed-author:HuangShenglinS,
pubmed-author:LiJinjunJ,
pubmed-author:LiangLinhuiL,
pubmed-author:PanZhimeiZ,
pubmed-author:WanDafangD,
pubmed-author:YaoXiaoX,
pubmed-author:ZhangPingpingP,
pubmed-author:ZhangZhenfengZ,
pubmed-author:ZhaoYingjunY
|
pubmed:copyrightInfo |
(c) 2008 Wiley-Liss, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
123
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
972-8
|
pubmed:meshHeading |
pubmed-meshheading:18508316-Apoptosis,
pubmed-meshheading:18508316-Carcinoma, Hepatocellular,
pubmed-meshheading:18508316-Cell Growth Processes,
pubmed-meshheading:18508316-Cell Line, Tumor,
pubmed-meshheading:18508316-Humans,
pubmed-meshheading:18508316-Lentivirus,
pubmed-meshheading:18508316-Liver Neoplasms,
pubmed-meshheading:18508316-MicroRNAs,
pubmed-meshheading:18508316-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:18508316-Smad Proteins,
pubmed-meshheading:18508316-Transfection,
pubmed-meshheading:18508316-Transforming Growth Factor beta,
pubmed-meshheading:18508316-Up-Regulation
|
pubmed:year |
2008
|
pubmed:articleTitle |
Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells.
|
pubmed:affiliation |
State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Medical School of Shanghai Jiaotong University, Shanghai, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|